SAINAGHI, Pier Paolo
 Distribuzione geografica
Continente #
NA - Nord America 10.263
EU - Europa 8.407
AS - Asia 5.491
SA - Sud America 930
Continente sconosciuto - Info sul continente non disponibili 504
AF - Africa 257
OC - Oceania 13
Totale 25.865
Nazione #
US - Stati Uniti d'America 9.723
RU - Federazione Russa 2.178
SG - Singapore 1.602
IT - Italia 1.586
IE - Irlanda 1.351
CN - Cina 1.071
DE - Germania 845
HK - Hong Kong 806
VN - Vietnam 758
BR - Brasile 686
SE - Svezia 599
FR - Francia 455
UA - Ucraina 367
GB - Regno Unito 302
CA - Canada 296
IN - India 271
BD - Bangladesh 218
FI - Finlandia 197
KR - Corea 154
ID - Indonesia 118
BJ - Benin 103
NL - Olanda 83
PL - Polonia 83
TR - Turchia 83
MX - Messico 82
AR - Argentina 80
AT - Austria 78
ZA - Sudafrica 69
CZ - Repubblica Ceca 63
JP - Giappone 62
ES - Italia 59
IQ - Iraq 50
IR - Iran 47
PK - Pakistan 47
BE - Belgio 44
CO - Colombia 32
VE - Venezuela 32
EC - Ecuador 31
CR - Costa Rica 28
PH - Filippine 28
LT - Lituania 24
CL - Cile 22
JM - Giamaica 22
CH - Svizzera 20
PY - Paraguay 20
SA - Arabia Saudita 19
TW - Taiwan 18
PE - Perù 17
TT - Trinidad e Tobago 17
MY - Malesia 16
HN - Honduras 15
AE - Emirati Arabi Uniti 14
GT - Guatemala 14
NP - Nepal 14
TH - Thailandia 14
AU - Australia 13
SV - El Salvador 12
EG - Egitto 11
MA - Marocco 11
TN - Tunisia 11
GP - Guadalupe 10
JO - Giordania 10
KE - Kenya 10
UZ - Uzbekistan 10
EE - Estonia 9
IL - Israele 9
DO - Repubblica Dominicana 8
NG - Nigeria 8
NI - Nicaragua 8
AZ - Azerbaigian 7
BB - Barbados 7
SN - Senegal 7
DK - Danimarca 6
DZ - Algeria 6
EU - Europa 6
OM - Oman 6
PT - Portogallo 6
RO - Romania 6
RS - Serbia 6
AM - Armenia 5
GR - Grecia 5
HR - Croazia 5
KZ - Kazakistan 5
LB - Libano 5
PR - Porto Rico 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
ET - Etiopia 4
LK - Sri Lanka 4
MD - Moldavia 4
MO - Macao, regione amministrativa speciale della Cina 4
SC - Seychelles 4
UY - Uruguay 4
BN - Brunei Darussalam 3
BW - Botswana 3
HU - Ungheria 3
LV - Lettonia 3
LY - Libia 3
Totale 25.321
Città #
Dublin 1.328
San Jose 1.209
Hong Kong 790
Council Bluffs 697
Ashburn 691
Singapore 670
Jacksonville 600
Chandler 333
Los Angeles 333
Beijing 308
Dearborn 244
Columbus 235
Novara 234
Moscow 230
Ho Chi Minh City 221
Wilmington 201
Lauterbourg 198
Houston 185
Santa Clara 175
New York 172
Hanoi 165
Munich 155
Milan 154
Princeton 150
Lawrence 149
Phoenix 145
Seoul 132
Piemonte 130
Buffalo 113
Ann Arbor 109
Cotonou 103
San Mateo 100
Orem 93
Turin 93
Dallas 92
São Paulo 90
Boardman 86
Jakarta 81
Nuremberg 77
Woodbridge 77
Frankfurt am Main 76
Toronto 70
Helsinki 66
Montreal 66
Warsaw 61
Vercelli 60
Brooklyn 57
Chennai 57
Bremen 55
Brno 51
Denver 50
Seattle 50
Atlanta 49
Turku 48
Falkenstein 47
Tokyo 47
Dong Ket 46
Rome 46
Johannesburg 45
London 45
Brussels 44
Chicago 44
Redondo Beach 44
Andover 43
Stockholm 41
Guangzhou 40
Amsterdam 38
The Dalles 38
Mülheim 37
Schaumburg 36
Haiphong 35
Mexico City 35
Vienna 34
Da Nang 32
Boston 30
Philadelphia 30
Poplar 28
Torino 27
Nanjing 25
San Francisco 25
Mumbai 24
St Louis 24
Tianjin 24
Ankara 22
Kocaeli 22
Brasília 21
Hefei 21
Las Vegas 21
North Bergen 21
Hangzhou 20
Ottawa 20
San José 20
Shanghai 20
Charlotte 19
Paris 19
Norwalk 18
Olathe 18
Palermo 18
Alessandria 17
Fairfield 17
Totale 13.552
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 411
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 275
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 214
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 210
Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2 209
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 207
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 205
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 198
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 197
Circulating Platelet-Derived Extracellular Vesicles Are a Hallmark of Sars-Cov-2 Infection 195
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 187
Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection 186
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 180
GAS6 induces proliferation in prostate carcinoma cell lines expressing the axl receptor 178
Change over time of COVID-19 hospital presentation in Northern Italy 175
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 174
Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritis 173
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 173
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 169
Metastatic mediastinal germ-cell tumor and concurrent COVID-19: when chemotherapy is not deferrable. 169
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 167
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 167
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 166
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients 166
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 166
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 166
Are Baseline Levels of Gas6 and Soluble Mer Predictors of Mortality and Organ Damage in Patients with Sepsis? The Need-Speed Trial Database 166
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein 166
Is cholecalciferol a potential disease modifying anti-rheumatic drug for the management of rheumatoid arthritis? 164
Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study. 163
Pattern of emergency department referral during the Covid-19 outbreak in Italy 163
A new method to distinguish the hyponatremia of electrolyte loss from that due to pure solvent changes 162
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 161
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 160
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 159
One-Year Follow up of Noninvasive Respiratory Support in General Wards 158
Higher Serum Monolaurin Is Associated with a Lower Risk of COVID-19: Results from a Prospective Observational Cohort Study 157
Association between rheumatic diseases and cancer: results from a clinical practice cohort study 157
Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis 157
Clinical stability and in-hospital mortality prediction in COVID-19 patients presenting to the Emergency Department 157
B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure 154
"war to the knife" against thromboinflammation to protect endothelial function of COVID-19 patients 154
Methods for the quantitative assessment of electrolyte disturbances in hyperglycaemia 151
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 151
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 151
L’impatto del Long COVID è stato minore nella terza ondata della pandemia rispetto alla prima ondata in una popolazione italiana di 324 pazienti. 149
A malignant fibroleiomyoma of the testis 147
Metabolomics diagnosis of covid-19 from exhaled breath condensate 147
An improved method to compute the solute and water derangements of hyperglycaemia 146
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 146
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 146
Exploring serum and CSF Calcitonin Gene Related Peptide levels: A promising biomarker in multiple sclerosis? 143
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 143
Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+ immune responses 142
Gas6 as a putative noninvasive biomarker of hepatic fibrosis 142
Plasma microvesicles in patients admitted to the emergency department for mild traumatic brain injury: First clues to understand their role 142
Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients 141
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 141
TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages 140
Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. 140
AORTIC INVOLVEMENT IN A RETROSPECTIVE COHORT OF LARGE VESSEL VASCULITIS PATIENTS 140
An Italian registry of chest pain patients in the emergency department: Clinical predictors of acute coronary syndrome 140
Understanding protection from SARS-CoV-2 using metabolomics 138
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 138
Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis 138
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 137
Hyperosmolar coma due to exclusive glucose accumulation: recognition and computations 137
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 137
Hempseed Water-Soluble Protein Fraction and Its Hydrolysate Display Different Biological Features 135
Comparison between HOMA-IR and ISI-gly in detecting subjects with the metabolic syndrome 133
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 133
Modelling hospital bed necessity for COVID-19 patients during the decline phase of the epidemic trajectory 133
Profiling the patients visiting the emergency room for musculoskeletal complaints: characteristics and outcomes 131
Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients 130
Progression from hidden to overt type 2 diabetes mellitus: significance of screening and importance of the laboratory 130
A case of false positive troponin I in a patient affected by cryoglobulinemic vasculitis 129
Cardiopulmonary exercise testing is an accurate tool for the diagnosis of pulmonary arterial hypertension in scleroderma related diseases 129
Red cell distribution width is a potential predictor of early relapse in polymyalgia rheumatica 129
Characterization of Circulating Vesicles of Complicated and Uncomplicated Systemic Sclerosis Patients and Their Role in Vascular Dysfunction 127
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized with COVID-19 Pneumonia: A Randomized Clinical Trial 127
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters 126
Acute pseudogout following intravenous neridronate for osteoporosis 126
Hypernatremia and moderate-to-severe hyponatremia are independent predictors of mortality in septic patients at emergency department presentation: A sub-group analysis of the need-speed trial 125
Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) 125
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 125
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19 125
Circulating Peptidome Is Strongly Altered in COVID-19 Patients 124
Alterazioni dell’equilibrio acido-base - Capitolo 52 124
Clinical Outcomes in Patients Aged 80 Years or Older Receiving Non-Invasive Respiratory Support for Hypoxemic Acute Respiratory Failure Consequent to COVID-19 124
Metabolic characteristics of glucose intolerance: the critical role of obesity 123
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 123
Poor specificity of fasting plasma glucose cut-off values in ruling out glucose intolerance: the complementary usefulness of OGTT 122
Quantitative assessment of the abnormalities of hyperosmolar coma when glucose excess is larger than Na deficit 122
Computation of the excess glucose and Na deficit of hypo-osmolar hyponatremic hyperglycaemia 122
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 121
COVID-19 Diagnosis in Case of Two Negative Nasopharyngeal Swabs: Association between Chest CT and Bronchoalveolar Lavage Results 120
Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis. 120
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 120
Risk of Severe Infection among Rheumatoid Arthritis Patients on Biological DMARDs: A Population-Based Cohort Study 120
Insights from Italy: the Novara-COVID score for rapid destination of COVID-19 patients at emergency department presentation 119
Totale 15.376
Categoria #
all - tutte 125.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.576


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022974 0 0 0 89 92 36 86 38 114 102 150 267
2022/20233.039 237 154 173 87 186 228 128 121 1.376 36 203 110
2023/20241.582 91 157 83 64 181 62 263 143 63 69 158 248
2024/20253.186 86 59 157 95 93 241 334 362 646 316 152 645
2025/202610.876 506 419 645 1.319 1.125 723 1.648 1.746 757 843 614 531
2026/20273.068 479 842 838 909 0 0 0 0 0 0 0 0
Totale 25.865